37 patents
Page 2 of 2
Utility
Topically administrable formulation for the control and prevention of animal parasites
31 May 22
The invention relates to novel liquid formulations suitable for topical administration to animals, which formulations comprise a fluorine-containing antiparasitic active compound and also triethyl phosphate, and to their use for the control and prevention of animal parasites.
Wolfgang Wiehl, Petra Ohage-Spitzlei, Franziska Schmidt
Filed: 3 Sep 18
Utility
Method for the hydrolysis of quinolonecarboxylic esters
17 May 22
Peter Fey, Mathias Berwe, Joerg Wirths, Ralf Wischnat, Markus Longerich, Antje Dietzel
Filed: 18 Apr 19
Utility
Monoclonal antibodies and methods of use
3 May 22
This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog.
Sarah Rue, Brendan Eckelman, Quinn L. Deveraux, Marc Nasoff
Filed: 24 Aug 17
Utility
Formulations for bovine granulocyte colony stimulating factor and variants thereof
15 Mar 22
This invention provides stable aqueous formulations comprising a bG-CSF polypeptide or a variant thereof, a buffer substance, and an excipient, wherein said formulation is substantially free of polyoxyethylene (20) sorbitan monolaurate.
Alan Voskamp Klotz, Catherine Ngan Kha, Juan Davagnino
Filed: 22 Sep 11
Utility
Animal intranasal administration device, systems, and associated methods
1 Mar 22
A veterinary subject intranasal administration device includes a first support member portion including a septum interface portion sized for insertion into a nasal passage of the veterinary subject; an actuation mechanism connected to the first support member portion; and a fluid conduit having a distal end opposite a supported end, the distal end sized for insertion into the nasal passage of the veterinary subject, the fluid conduit being flexible and configured to receive fluid from a fluid source and discharge the fluid through the distal end into the nasal passage, the distal end of the fluid conduit being unsupported and movable relative to the septum interface portion.
Amy L. Marr, Jane Granville Owens, Jeffrey Kyle Hill, Casey J. Strange, Randall Lee Waln, Christopher C. Miller, Gilly Regev-Shoshani, Alex Stenzler, Steve Han
Filed: 19 Jul 17
Utility
Quinoline derivatives for treating infections with helminths
22 Feb 22
Nils Griebenow, Wei Zhuang, Daniel Kulke, Claudia Böhm, Hans-Georg Schwarz, Walter Hübsch, Thomas Ilg
Filed: 30 Jul 18
Utility
Tablets with improved acceptance and good storage stability
19 Oct 21
The present invention relates to tablets for animals, having improved acceptance and good storage stability.
Venkata-Rangarao Kanikanti, Hans-Juergen Hamann, Georg Schulte, Patrick Billian
Filed: 16 Dec 19
Utility
Bicyclic pyrazole derivatives
28 Sep 21
Nils Griebenow, Wei Zhuang, Daniel Kulke, Adeline Köhler, Thomas Ilg, Claudia Welz, Hans-Georg Schwarz, Ulrich Görgens, Walter Hübsch, Johannes Köbberling
Filed: 23 Apr 18
Utility
Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals
3 Aug 21
The present application relates to the use of fused heteroaromatic pyrrolidones for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals and to the use thereof for production of medicaments for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially of atopic dermatitis and/or Flea Allergy Dermatitis, and especially in domestic animals, particularly in dogs.
Nils Griebenow, Maria De Lourdes Mottier, Gerald Beddies, Jörg Cramer, Ulf Bömer, Iring Heisler
Filed: 15 Oct 18
Utility
Pyrazolopyrimidine derivatives
11 May 21
Hans-Georg Schwarz, Adeline Köhler, Nils Griebenow, Wei Zhuang
Filed: 29 Jan 20
Utility
Pegylated porcine interferon and methods of use thereof
30 Mar 21
Disclosed herein are porcine interferon alpha variants (pIFN-α) comprising a synthetic amino acid at select locations in pIFN-α and a one or two amino acid insertion in the N-terminus after removal of the signal peptide.
Peter Connor Canning, Nickolas Knudsen, Lillian Skidmore
Filed: 16 Jun 17
Utility
Chimeric canine anti-CD20 antibody
9 Mar 21
The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
James David Pancook
Filed: 14 Nov 19
Utility
Increased fertility in bovine species
2 Mar 21
The present invention relates to compositions and methods for immunomodulation which are effective for increasing conception rate in cows.
Jason Nickell, Daniel Keil, Albert Abraham, Warren Tully, Richard Gerhardus Martinu Olde Riekerink, Terry Settje, Leland Vickers, Stuart Nibbelink
Filed: 25 Jul 17
Utility
Pyrazolopyrimidine derivatives
2 Mar 21
Ulrich Görgens, Claudia Welz, Daniel Kulke, Claudia Böhm
Filed: 29 Jan 20
Utility
Compositions for treatment of heart failure in dogs
28 Dec 20
The invention relates to a new fixed dose combination of benazepril with pimobendan.
Jernej Grmas, Zdenka Jerala-Strukelj, Sebastjan Reven
Filed: 18 Dec 12
Utility
Preparation of live vaccines
9 Nov 20
Described is a method for the generation of a live vaccine containing stable bacteria carrying at least three attenuating mutations and a vaccine containing bacteria obtained by said method.
Klaus Linde, Anke Grosse-Herrenthey
Filed: 4 Sep 13
Utility
Anti-canine platelet derived growth factor receptor alpha antibody
13 Jul 20
The present disclosure relates to anti-canine platelet derived growth factor receptor alpha antibodies binding to canine platelet derived growth factor receptor alpha.
Douglas Bryan Burtrum, Dale Lincoln Ludwig, Juqun Shen, Cheng Wang
Filed: 19 Jul 17